Evidence map›Paper›PMID 36261842›Full record

ArticleJournal of neuroinflammation2022

ISGylation is induced in neurons by demyelination driving ISG15-dependent microglial activation.

Benjamin D S Clarkson, Ethan Grund, Kenneth David, Renee K Johnson, Charles L Howe

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. When ISG15 is involved in inflammation.Frontiers in immunology · 2026
    Review
  6. Extracellular RNAs as Messengers and Early Biomarkers in Neurodegeneration.International journal of molecular sciences · 2025
    Review
  7. Review
  8. Review
  9. Article
  10. Molecular Interplay of ISG15/ISGylation in Neuropathologies.CNS & neurological disorders drug targets · 2025
    Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Benjamin D S ClarksonDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA. Clarkson.benjamin@mayo.edu.
Ethan GrundDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Kenneth DavidConcordia College, Moorhead, MN, USA.
Renee K JohnsonDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Charles L HoweDepartment of Neurology, Mayo Clinic, Rochester, MN, 55905, USA.
Mayo Clinic · USConcordia College - Minnesota · USWinnMed · US

Funding

Neuronal antigen surveillance and autoimmunity in CNS demyelinating diseaseR01NS115126 · NINDS · MAYO CLINIC ROCHESTER · PI HOWE, CHARLES LEE · 2020 to 2024
$2.9M
Center for MS and Autoimmune Neurology, Mayo Clinic Pilot AwardNational Multiple Sclerosis Society Postdoctoral FellowshipNINDS NIH HHS R01 NS115126Stichting MS Research Global MS Research Booster Award
6 · The paper itself

Abstract

The causes of grey matter pathology and diffuse neuron injury in MS remain incompletely understood. Axonal stress signals arising from white matter lesions has been suggested to play a role in initiating this diffuse grey matter pathology. Therefore, to identify the most upstream transcriptional responses in neurons arising from demyelinated axons, we analyzed the transcriptome of actively translating neuronal transcripts in mouse models of demyelinating disease. Among the most upregulated genes, we identified transcripts associated with the ISGylation pathway. ISGylation refers to the covalent attachment of the ubiquitin-like molecule interferon stimulated gene (ISG) 15 to lysine residues on substrates targeted by E1 ISG15-activating enzyme, E2 ISG15-conjugating enzymes and E3 ISG15-protein ligases. We further confirmed that ISG15 expression is increased in MS cortical and deep gray matter. Upon investigating the functional impact of neuronal ISG15 upregulation, we noted that ISG15 expression was associated changes in neuronal extracellular vesicle protein and miRNA cargo. Specifically, extracellular vesicle-associated miRNAs were skewed toward increased frequency of proinflammatory and neurotoxic miRNAs and decreased frequency of anti-inflammatory and neuroprotective miRNAs. Furthermore, we found that ISG15 directly activated microglia in a CD11b-dependent manner and that microglial activation was potentiated by treatment with EVs from neurons expressing ISG15. Further study of the role of ISG15 and ISGylation in neurons in MS and neurodegenerative diseases is warranted.

Indexed as

Demyelinating DiseasesMicroRNAsAnimalsCytokinesInterferonsLysineMiceMicrogliaNeuronsUbiquitin-Protein LigasesUbiquitinsCytokinesInterferonsLysineMicroRNAsUbiquitin-Protein LigasesUbiquitinsExosomesExtracellular vesiclesISG15ISGylationmiRNAMultiple sclerosis

Identifiers

PMID36261842
PMCPMC9583544
OpenAlexW4306910303

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.